Alpha Cognition Inc ACOG 深 滬
已收盤 02-06 16:00:00 美东时间
5.10
+0.600
+13.33%
華盛通- 最 高5.1999
- 今 開4.65
- 成交量 2.87万股
- 最 低 4.60
- 昨 收 4.50
- 總市值 1.11亿
- 52周最高 11.54
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 3.75
- 委 比 -98.30%
- 總股本 2174.21万
- 歷史最高 11.54
- 量 比 0.44
- 振 幅 13.33%
- 歷史最低 3.75
- 每 手 1
- 風險率 1.80%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Alpha Cognition Targets 2,000 ZUNVEYL Prescribers In 2026; Plans 3 Long-Term Care Alzheimer's Studies; Anticipates $3M Asia Licensing Milestone; Aims For Operating Profitability In 2027
ZUNVEYL prescriber base expected to expand to approximately 2,000 prescribing healthcare providers, and an increase in nursing home penetrationCompany expects to complete and/or initiate three studies in 2026 supporting
01-08 05:35
美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
2025-12-22 15:05
HC Wainwright & Co. Reiterates Buy on Alpha Cognition, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Alpha Cognition (NASDAQ:ACOG) with a Buy and maintains $18 price target.
2025-12-19 20:59
Alpha Cognition Q3 Sales $2.300M Beat $2.033M Estimate
Alpha Cognition (NASDAQ:ACOG) reported quarterly sales of $2.300 million which beat the analyst consensus estimate of $2.033 million by 13.16 percent.
2025-11-14 05:04
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
2025-10-21 18:13
Alpha Cognition To Present New Clinical Insights On Cholinesterase Inhibitors And ZUNVEYL At The American Society Of Consultant Pharmacists Annual Meeting On October 23–25, 2025, And The Neuroscience Education Institute Annual Congress On November 6–9, 2025
Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition" or the "Company"), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced it will present new
2025-10-15 04:33
Alpha Cognition prices $35M public offering of common shares
Alpha Cognition (NASDAQ:ACOG) has priced its underwritten public offering of 5.6M common shares (or pre-funded warrants in lieu thereof), at $6.25 per share for gross proceeds of $35.0 million. The un...
2025-10-01 11:55
Alpha Cognition Reveals Proposed Public Offering of Common Shares; No Size Disclosed
Alpha Cognition Inc. (NASDAQ:ACOG) (the "Company"), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases, today announced that it is proposing to offer
2025-10-01 04:59
Alpha Cognition Q2 EPS $(0.65) Misses $(0.46) Estimate, Sales $1.657M Inline
Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.46) by 41.3 percent. This is a 109.68 percent decrease over losses of $(0.31) per share from
2025-08-15 04:11
